Physiopathology of human embryonic implantation: Clinical incidences

Folia Histochemica et Cytobiologica

Volumn 47, Issue 5, 2009, Pages

  Merviel, Philippe ^a   Lourdel, Emmanuelle ^a   Cabry, Rosalie ^a   Boulard, Véronique ^a   Brzakowski, Mélanie ^a   Demailly, Pauline ^a   Brasseur, Françoise ^a   Copin, Henri ^a   Devaux, Aviva ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Endometrium; Implantation; Preeclampsia; Progesterone; Trophoblast

Indexed keywords

ACETYLSALICYLIC ACID; CADHERIN; CYTOKINE; ESTRADIOL; HYDROXYPROGESTERONE; INTEGRIN; MATRIX METALLOPROTEINASE; PLATELET DERIVED GROWTH FACTOR; SILDENAFIL; STEROID 21 MONOOXYGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLOTRANSPLANTATION; CLINICAL TRIAL; CYTOTROPHOBLAST; DECIDUA; DECIDUALIZATION; EMBRYO DEATH; ENDOMETRIUM; FETOPLACENTAL UNIT; HORMONE RELEASE; HUMAN; HYDROSALPINX; IMMUNOLOGY; LUTEAL PHASE; NIDATION; NUTRIENT; PATHOPHYSIOLOGY; PLACENTA DEVELOPMENT; PREECLAMPSIA; PROTEIN EXPRESSION; REVIEW; THROMBOPHILIA; TROPHOBLAST; UTERINE ARTERY; UTERINE BLOOD VESSEL; UTERUS BLOOD FLOW; UTERUS CONTRACTION; VASOMOTOR REFLEX; INCIDENCE; METABOLISM; PLACENTA;

EMBRYO IMPLANTATION; ENDOMETRIUM; HUMANS; INCIDENCE; PLACENTA; TROPHOBLASTS;

EID: 75949087951     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0058-3     Document Type: Review

References (48)

1. Giudice LC, Saleh W. Growth factors in reproduction. Trends Endocrinol Metab. 1995;6:60-69.
2. Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally and orally. Fertil Steril. 2001;75:200-202.
3. Battaglia C, Regnani G, Marsella T, Facchinetti F, Volpe A, Venturoli S, Flamigni C. Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. Hum Reprod. 2002;17:659-665.
4. Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000;15:806-809.
5. Fanchin R, Righini C, Ayoubi JM, Olivennes F, de Ziegler D, Frydman R. New look at endometrial echogenicity: objective computer-assisted measurement predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril. 2000;74:274-281.
6. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122:262-263.
7. Tabibzadeh S, Babaknia A. The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod. 1995;10:1579-1602.
8. Lessey BA, Castelbaum AJ, Buck CA, Lei Y, Yowell CW, Sun J. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy. Fertil Steril. 1994;62:497-506.
9. Lessey BA, Castelbaum AJ, Sawin SJ, Buck CA, Shinnar R, Wilkins B. Abberant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab. 1994;79:643-649.
10. Creus M, Balasch J, Ordi J, Fabregues F, Casamitjana R, Quinto L, Coutifaris C, Vanrell JA. Integrin expression in normal and out-of-phase endometria. Hum Reprod. 1998;13:3460-3468.
11. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK, Fisher SJ. Integrin switching regulates normal trophoblast invasion. Development. 1994;120:3657-3666.
12. Pijnenborg R. Establishment of uteroplacental circulation. Reprod Nutr Develop. 1988;28:1581-1586.
13. Meekins JW, Luckas MJM, Pijnenborg R, Mc Fadyen IR. Histological study of decidual spiral arteries and the presence of maternal erythrocytes in the intervillous space during the first trimester of normal human pregnancy. Placenta. 1997;18:459-464.
14. Hansen V, Maigaard S, Allen J, Forman A. Effects of vasoactive intestinal polypeptide and substance P on human intramyometrial arteries and stem villous arteries in term pregnancy. Placenta. 1988;9:501-506.
15. Ignarro LJ. Biosynthesis and metabolism of endotheliumderived nitric oxide. Ann Rev Pharmacol Toxicol. 1990;30:535-569.
16. Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996;17:401-405.
17. Jaffe R, Dorgan A, Abramowicz JS. Color Doppler imaging of uteroplacental circulation in the first trimester: value in prediction pregnancy failure or complication. AJ R. 1995;164:1255-1258.
18. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111-2122.
19. Kam EP, Gardner L, Loke YW, King A. The rôle of trophoblast in the physiological change in decidual spiral arteries. Hum Reprod. 1999;14:2131-2138.
20. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T. Uterine artery doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol. 1995;85:760-765.
21. Vicovac L, Aplin JD. Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anat. 1996;156:202-216.
22. Aplin JD. Hypoxia and human placental development. J Clin Invest. 2000;105:559-560.
23. Goffin F, Malassine A, Evain-Brion D, Munaut C, Frankenne F, Fridman V, Dubois M, Uzan S, Merviel P, Foidart JM. Evidence of a limited contribution of feto-maternal interactions to trophoblast differentiation along the invasive pathway. Tissue Antigens. 2003;62:104-116.
24. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
25. O'Shaughnessy KM, Fu B, Ferraro F, Lewis I, Downing S, Morris NH. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension. 1999;33:1338-1341.
26. Rigo J, Nagy B, Fintor L, Tanyi J, Beke A, Karadi I. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000;19:163-172.
27. Myatt L. Current topic: control of vascular resistance in the human placenta. Placenta 1992;13:329-341.
28. Mac Mahon LP, Redman CWG, Firth JD. Expression of the three endothelin genes and plasma levels of endothelin in preeclamptic and normal gestations. Clinical Science 1993; 85:417-424.
29. Mac Queen J, Kingdom JC, Connell JM, Whittle MJ. Fetal endothelin levels and placental endothelin receptors in intrauterine growth retardation. Obstet Gynecol. 1993;82: 992-998.
30. Jovanovic A, Grbovic L, Tilic I. Predominant role for nitric oxide in the relaxation induced by acetyl-choline in human uterine artery. Hum Reprod. 1994;9:387-393. (Pubitemid 24096386)
31. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319-1330.
32. Mabry White M, Zamudio S, Stevens T. Estrogen, Progesterone, and vascular reactivity: potential cellular mecanisms. Endoc Rev. 1997;16:739-751.
33. Davidge ST, Hubel CA, Mc Laughlin MK. Lipid peroxidation increases arterial cyclooxygenase activity during pregnancy. Am J Obstet Gynecol. 1994;170:215-222.
34. Clifton VL, Read MA, Boura ALA, Robinson PJ, Smith R. Adrenocorticotropin causes vasodilatation in the human fetalplacenta circulation. J Clin Endoc Metab. 1996;81:1406-1410.
35. Carter TL, Park P, Pratt K. Effects of CGRPa on the migration of endothelial cells of human origin. FASEB J. 1993;7:125.
36. Yallampalli C, Dong YL, Wimalawansa SJ. Calcitonin generelated peptide reverses the hypertension and significantly decreases the fetal mortality in pre-eclampsia rats induced by NG-nitro-L-Arginine methyl ester. Hum Reprod. 1996;11: 895-899.
37. Knight KB, Keith RE. Calcium supplementation on normotensive and hypertensive pregnant women. Am J Clin Nutr. 1992;55:891-895.
38. Sanchez-Ramos L, Briones DK, Kaunitz AM, Delvalle GO, Gaudier FL, Walker CD. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin IIsensitive patients. Obstet Gynecol. 1994;84:349-353.
39. Fanchin R, Righini C, Olivennes F, Taylor S, de Ziegler D, Frydman R. Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization. Hum Reprod. 1998;13:1968-1974.
40. Merviel P, Challier JC, Carbillon L, Foidart JM, Uzan S. The role of integrins in human embryo implantation. Fetal Diagn Ther. 2001;16:364-371.
41. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest. 1993;91:950-960.
42. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblast to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99:2152-2164.
43. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/ invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 1996;97:540-550.
44. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985;152:335-340.
45. Tsukimori K, Maeda H, Shingu M, Koyanagi T, Nobunaga M, Nakano H. The possible role of endothelial cells in hypertensive disorders during pregnancy. Obstet Gynecol. 1992; 80:229-233.
46. Uzan S, Merviel P, Beaufils M, Breart G, Salat-Baroux J. Aspirin during pregnancy. Indications and modalities of prescription after the publication of the later trials. Presse Med. 1996;25:31-36 .
47. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, Aznar J, Loskutoff DJ. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost. 1998;79:500-508.
48. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499-506.